| ¡ Regístrese ahora en R3i! PP Toth, RJ Simko, SR Palli | | |
| † Safety and Efficacy of Bempedoic Acid in Patients with Renal Impairment A Catapano, B Helms, L Lei, M Louie, G Bakris, P Toth Journal of Clinical Lipidology 16 (3), e56, 2022 | 2 | 2022 |
| 1, 25 (OH) 2 Vitamin D Inhibits Foam Cell Formation and Suppresses Macrophage Cholesterol Uptake in Patients With Type 2 Diabetes Mellitus Oh J, Weng S, Felton SK, et al … PP Toth Year Book of Endocrinology 2010, 80-82, 2010 | | 2010 |
| 1% DONATIONS IN FIVE HUNGARIAN TOWNS P Toth TER ES TARSADALOM 24 (2), 121-137, 2010 | | 2010 |
| 1443 Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials F Fogacci, M Banach, DP Mikhailidis, E Bruckert, PP Toth, GF Watts, ... European Heart Journal 40 (Supplement_1), ehz748. 0078, 2019 | | 2019 |
| 2023: The year in cardiovascular disease–the year of new and prospective lipid lowering therapies. Can we render dyslipidemia a rare disease by 2024? M Banach, S Surma, PP Toth Archives of Medical Science: AMS 19 (6), 1602, 2023 | 14 | 2023 |
| 23-LB: Lipoprotein Subfractions Are Associated with Diabetic Cardiovascular Disease and Death among 9,795 Patients in the FIELD Trial SR Jones, AJ Jenkins, AS Januszewski, RL Oconnell, L Li, D Sullivan, ... Diabetes 68 (Supplement_1), 2019 | 1 | 2019 |
| 253 SAFETY PROFILE OF STATINS ALONE OR COMBINED WITH EZETIMIBE: A POOLED ANALYSIS OF OVER 21,000 PATIENTS PP Toth, W Weintraub, D Morrone, ME Hanson, RS Lowe, J Lin, A Shah, ... Atherosclerosis (Supplements)(Component) 1 (12), 55, 2011 | | 2011 |
| 3100 Effects of morning versus evening statin therapy on lipid profile: a systematic review and meta-analysis K Awad, MC Serban, P Penson, DP Mikhailidis, PP Toth, SR Jones, ... European Heart Journal 38 (suppl_1), ehx504. 3100, 2017 | | 2017 |
| 3104 Associations between cardiovascular disease, cancer and very low hdl cholesterol in the reasons for geographical and racial differences in stroke (REGARDS) study P Penson, DL Long, G Howard, VJ Howard, SR Jones, SS Martin, ... European Heart Journal 38 (suppl_1), ehx504. 3104, 2017 | | 2017 |
| 41-LB: Lipoprotein Subfractions Are Associated with Diabetic Microvascular Disease among 9,795 Patients in the FIELD Trial PP Toth, AC Keech, AS Januszewski, RL Oconnell, L Li, D Sullivan, ... Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 45 Association of types of dietary fats and all-cause and cause-specific mortality: a prospective cohort study and meta-analysis of prospective studies with 1,148,117 participants M Mazidi, DP Mikhailidis, N Sattar, PP Toth, S Judd, MJ Blaha, ... European Heart Journal 40 (Supplement_1), ehz747. 0005, 2019 | 2 | 2019 |
| 572-P: Association of Sight-Threatening Diabetic Retinopathy in Type 1 Diabetes with Subclinical Atherosclerosis Disease Burden: Five-Year Indian Study K Shah, N Sundaram, LS Purohit, PP Toth, AR Kothari, S Gupta Diabetes 69 (Supplement_1), 2020 | | 2020 |
| 616-P: Long-Term Statin Persistence Is Poor among High-Risk Patients with Baseline Diabetes: A Real-World Administrative Claims Analysis PP Toth, S Philip, M Hull, CB Granowitz Diabetes 68 (Supplement_1), 2019 | | 2019 |
| 75 EFFICACY OF EZETIMIBE/STATINS AND STATIN MONOTHERAPY AND FACTORS ASSOCIATED WITH TREATMENT RESPONSE: POOLED ANALYSIS OF> 21,000 SUBJECTS FROM 27 TRIALS PP Toth, D Morrone, W Weintraub, ME Hanson, RS Lowe, J Lin, A Shah, ... Atherosclerosis (Supplements)(Component) 1 (12), 18, 2011 | 1 | 2011 |
| 80 CHANGES IN LDL-C LEVELS AND GOAL ATTAINMENT ASSOCIATED WITH ADDING EZETIMIBE ONTO SIMVASTATIN, ATORVASTATIN AND ROSUVASTATIN COMPARED WITH TITRATING STATINS JM Foody, PP Toth, S Sajjan, DR Ramey, DR Neff, AM Tershakovec, H Hu, ... Atherosclerosis (Supplements)(Component) 1 (12), 19, 2011 | | 2011 |
| 81 Efficacy and safety of alternate-day versus daily dosing of statins: a systematic review and meta-analysis K Awad, DP Mikhailidis, PP Toth, SR Jones, P Moriarty, GYH Lip, ... European Heart Journal 38 (suppl_1), ehx501. 81, 2017 | | 2017 |
| A clinician's guide to statin drug-drug interactions KA Kellick, M Bottorff, PP Toth Journal of clinical lipidology 8 (3), S30-S46, 2014 | 188 | 2014 |
| A Commentary on the implications of the ENHANCE (Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression) Trial: Should ezetimibe move to the … PP Toth, KC Maki Journal of Clinical Lipidology 2 (5), 313-317, 2008 | 19 | 2008 |
| A comparison of the attainment of guideline-recommended LDL-C lowering with statin and ezetimibe+ statin therapies PP Toth, H Bays, M Farnier, E Jensen, JE Tomassini, A Polis, J Lin, S Bird, ... Atherosclerosis 263, e240-e241, 2017 | | 2017 |
Maciej BanachSecretary, European Atherosclerosis Society & President, International Lipid Expert Panel; Poland在 umed.lodz.pl 的电子邮件经过验证
